Drug factory · FDA FEI 3008418820
Currenta GmbH & Co. OHG
Kaiser-Wilhelm-Allee 80, Leverkusen, Germany
Problems found, fixed voluntarily at FDA's last inspection, Feb 15, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2015: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Gadolinium Cation (3+) | Tests it | Bayer HealthCare Pharmaceuticals Inc. | 50419-325 |
| Oteseconazole | Tests it | Mycovia Pharmaceuticals, Inc. | 74695-823 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 15, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 6, 2020 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 19, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.